SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-080153
Filing Date
2014-11-13
Accepted
2014-11-13 10:24:43
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-22518_110q.htm 10-Q 852607
2 EX-31.1 a14-22518_1ex31d1.htm EX-31.1 12690
3 EX-31.2 a14-22518_1ex31d2.htm EX-31.2 12669
4 EX-32.1 a14-22518_1ex32d1.htm EX-32.1 6914
  Complete submission text file 0001104659-14-080153.txt   3675208

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mrns-20140930.xml EX-101.INS 424921
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrns-20140930.xsd EX-101.SCH 25415
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrns-20140930_cal.xml EX-101.CAL 30207
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrns-20140930_def.xml EX-101.DEF 107341
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mrns-20140930_lab.xml EX-101.LAB 262616
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrns-20140930_pre.xml EX-101.PRE 198454
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 141216689
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences